Reneo Pharmaceuticals Probability of Future Stock Price Finishing Under 1.55
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Reneo |
Reneo Pharmaceuticals Target Price Odds to finish below 1.55
The tendency of Reneo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 1.55 or more in 90 days |
| 18.20 | 90 days | 1.55 | near 1 |
Based on a normal probability distribution, the odds of Reneo Pharmaceuticals to drop to $ 1.55 or more in 90 days from now is near 1 (This Reneo Pharmaceuticals probability density function shows the probability of Reneo Stock to fall within a particular range of prices over 90 days) . Probability of Reneo Pharmaceuticals price to stay between $ 1.55 and its current price of $18.2 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Reneo Pharmaceuticals has a beta of 0.17 indicating as returns on the market go up, Reneo Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Reneo Pharmaceuticals will be expected to be much smaller as well. Additionally Reneo Pharmaceuticals has an alpha of 0.3038, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Reneo Pharmaceuticals Price Density |
| Price |
Predictive Modules for Reneo Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reneo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Reneo Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Reneo Pharmaceuticals is not an exception. The market had few large corrections towards the Reneo Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Reneo Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Reneo Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 0.99 | |
Ir | Information ratio | 0.06 |
Reneo Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Reneo Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Reneo Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Reneo Pharmaceuticals is now traded under the symbol OKUR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Reneo Pharmaceuticals is not yet fully synchronised with the market data | |
| Reneo Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Reneo Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Reneo Pharmaceuticalshas 3,398,311 shares shorted by Reneo Pharmaceuticals investors is about 100% of outstending shares | |
| Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reneo Pharmaceuticals currently holds about 126.85 M in cash with (63.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.18. | |
| Over 88.0% of the company shares are owned by institutional investors |
Reneo Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Reneo Stock often depends not only on the future outlook of the current and potential Reneo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reneo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.7 M | |
| Cash And Short Term Investments | 103 M |
Reneo Pharmaceuticals Technical Analysis
Reneo Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Reneo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Reneo Pharmaceuticals. In general, you should focus on analyzing Reneo Stock price patterns and their correlations with different microeconomic environments and drivers.
Reneo Pharmaceuticals Predictive Forecast Models
Reneo Pharmaceuticals' time-series forecasting models is one of many Reneo Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Reneo Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Reneo Pharmaceuticals
Checking the ongoing alerts about Reneo Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Reneo Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Reneo Pharmaceuticals is now traded under the symbol OKUR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Reneo Pharmaceuticals is not yet fully synchronised with the market data | |
| Reneo Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Reneo Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Reneo Pharmaceuticalshas 3,398,311 shares shorted by Reneo Pharmaceuticals investors is about 100% of outstending shares | |
| Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reneo Pharmaceuticals currently holds about 126.85 M in cash with (63.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.18. | |
| Over 88.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |